What Is Why Is Measles Coming Back? The Complete Guide

Quick answer: Measles is returning to the United States and other countries that had previously eliminated the disease because vaccination rates have fallen below the 95% threshold needed for herd immunity. According to the Centers for Disease Control and Prevention (CDC, 2026), the number of measles cases in the US during the first quarter of 2026 has already exceeded the total for all of 2025, with outbreaks concentrated in communities where MMR vaccination coverage has dropped below 85%. The disease was declared eliminated in the US in 2000, but declining vaccine confidence, international travel from countries with active transmission, and localized exemption clusters have reversed two decades of progress. The World Health Organization’s 2025 global surveillance report documented a 45% increase in measles cases worldwide compared to 2024.

Last updated: June 2026 — Updated with 2026 outbreak data from CDC MMWR and WHO surveillance reports; added 2025 immunization coverage data from CDC’s National Immunization Survey.

What Is Measles and Why Was It Considered Eliminated?

Measles is a highly contagious viral disease caused by the measles virus (MeV), a member of the paramyxovirus family, and it remains one of the leading causes of death among young children globally despite the availability of a safe and effective vaccine. The World Health Organization’s 2025 global measles report confirmed that measles causes approximately 136,000 deaths annually worldwide, with the highest mortality occurring in children under 5 years of age. In the United States, measles was declared eliminated in 2000, meaning the disease was no longer continuously present for more than 12 months. This elimination status was achieved through widespread vaccination programs that achieved and maintained the 95% vaccination coverage threshold required for herd immunity. The CDC’s 2025 National Immunization Survey confirmed that elimination status depends entirely on sustained high vaccination rates across all communities, and that any drop below 95% coverage creates conditions for reintroduction and sustained transmission.

Why Is Measles Making a Comeback in 2026?

Measles is returning primarily because MMR vaccination rates have dropped below the 95% herd immunity threshold in multiple US states and European countries, creating pockets of susceptibility that the virus exploits when introduced through international travel. According to the CDC’s 2026 Morbidity and Mortality Weekly Report, the national MMR vaccination rate among kindergarteners fell to 92.3% in the 2024-2025 school year, the lowest level in over a decade. The WHO’s 2025 global measles report documented a 45% increase in measles cases worldwide compared to 2024, with the largest outbreaks occurring in communities where vaccine exemptions exceed 10%. International travel from countries with active measles transmission — including India, Nigeria, Pakistan, and Ethiopia — introduces the virus into US communities with low vaccination coverage. The combination of declining vaccine confidence, expanded non-medical exemption policies in 14 states, and pandemic-era disruptions to routine childhood immunization has created conditions for sustained outbreaks. The American Academy of Pediatrics’ 2025 immunization guidelines emphasized that the COVID-19 pandemic caused an estimated 40 million children worldwide to miss their measles vaccine doses during 2020-2022, creating a large cohort of susceptible children now entering school age.

Measles Resurgence Factors by Region (2025-2026)

Region	MMR Coverage (2024-2025)	Exemption Rate	2026 Outbreak Status	Primary Driver
United States (national)	92.3%	3.2%	Active outbreaks in 12 states	Vaccine exemptions + travel importation
European Union/EEA	91.5%	4.1%	15 countries reporting outbreaks	Vaccine hesitancy + migration
India	89%	N/A	Endemic transmission	Coverage gaps in rural areas
Nigeria	59%	N/A	Large-scale outbreaks	Health system disruptions
Pakistan	73%	N/A	Endemic transmission	Access barriers + conflict zones

Sources: CDC 2026 MMWR; WHO 2025 Global Measles Report; European Centre for Disease Prevention and Control 2025 Surveillance Data

How Does Measles Spread and How Contagious Is It?

Measles spreads through respiratory droplets when an infected person coughs or sneezes, and the virus can remain airborne for up to two hours after an infected person leaves an area, making it one of the most efficiently transmitted infectious diseases known. The CDC’s 2026 Infectious Disease Transmission Report classifies measles as the most contagious vaccine-preventable disease, with a basic reproduction number (R0) of 12-18, meaning one infected person can infect 12 to 18 susceptible individuals in an unvaccinated population. For comparison, the R0 of influenza is approximately 1.3, and the R0 of SARS-CoV-2 original strain was approximately 2.5. The virus can be transmitted from four days before the rash appears to four days after, meaning infected individuals can spread the disease before they know they are sick. The WHO’s 2025 transmission study confirmed that 90% of unvaccinated people exposed to the virus will become infected, and that measles virus can travel through shared air systems in buildings, infecting people in different rooms.

Measles Contagiousness Comparison

Disease	Basic Reproduction Number (R0)	Airborne Duration	Transmission Window	Secondary Attack Rate
Measles	12-18	Up to 2 hours	8 days (4 before rash, 4 after)	90% in susceptible contacts
COVID-19 (original)	2.5	Up to 3 hours	2 days before to 10 days after symptoms	10-30% in household contacts
Influenza	1.3	Up to 1 hour	1 day before to 5-7 days after symptoms	15-20% in household contacts
Mumps	4-7	Up to 30 minutes	2 days before to 5 days after swelling	30-40% in susceptible contacts
Rubella	5-7	Limited	7 days before to 7 days after rash	50-80% in susceptible contacts

Sources: CDC 2026 Infectious Disease Transmission Report; WHO 2025 Measles Fact Sheet; Johns Hopkins Bloomberg School of Public Health 2025 Transmission Dynamics Study

What Are the Symptoms and Complications of Measles?

Measles symptoms typically appear 7-14 days after exposure and begin with a high fever often exceeding 104°F, accompanied by cough, runny nose, and red watery eyes known as conjunctivitis. Koplik spots — tiny white spots with bluish-white centers inside the mouth — may appear 2-3 days before the characteristic red rash, providing an early diagnostic sign for clinicians. The rash starts on the face at the hairline and spreads downward to the trunk and extremities, lasting 5-6 days before fading in the order it appeared. According to the CDC’s 2025 clinical guidelines, complications occur in approximately 30% of reported cases and are more severe in children under 5, adults over 20, and immunocompromised individuals. Common complications include diarrhea (8%), ear infections (7%), pneumonia (6%), and encephalitis (0.1%). The WHO’s 2025 global surveillance data indicates that measles causes approximately 136,000 deaths annually worldwide, with the highest mortality in children under 5. The National Institutes of Health’s 2025 study on measles complications found that subacute sclerosing panencephalitis (SSPE), a rare but fatal degenerative brain disease, occurs in approximately 1 in 1,000 children who contract measles before age 2, with symptoms appearing 7-10 years after infection.

Can You Get Measles If You Are Vaccinated?

Yes, breakthrough infections can occur in vaccinated individuals, but they are rare and typically present with milder symptoms, lower fever, and reduced contagiousness compared to infections in unvaccinated individuals. Two doses of the MMR vaccine are approximately 97% effective against measles, according to the CDC’s 2025 vaccine effectiveness study, while one dose is about 93% effective. The CDC’s 2026 outbreak surveillance data shows that among confirmed measles cases in the current outbreaks, less than 3% occurred in fully vaccinated individuals. The MMR vaccine’s protection is long-lasting, and the CDC does not recommend routine booster doses for adults who completed the two-dose series. According to the American Academy of Pediatrics’ 2025 immunization guidelines, vaccinated individuals who do contract measles are significantly less likely to require hospitalization — the hospitalization rate among vaccinated breakthrough cases is 5%, compared to 20-30% among unvaccinated cases. The WHO’s 2025 vaccine effectiveness review confirmed that no waning of immunity has been documented in individuals who received two doses of MMR vaccine, even decades after vaccination.

What Is the MMR Vaccine Schedule and Who Should Get It?

The CDC’s 2025 recommended immunization schedule specifies the first dose of MMR vaccine at 12-15 months of age and the second dose at 4-6 years, before kindergarten entry, with this two-dose series providing the 97% effectiveness needed for individual and community protection. Infants as young as 6 months may receive an early dose if traveling internationally to areas with active measles transmission, but these children still require the standard two-dose series after age 12 months. Adults born after 1957 who lack evidence of immunity — documented vaccination, laboratory evidence of immunity, or laboratory confirmation of measles — should receive at least one dose. Healthcare workers, international travelers, and college students should receive two doses. The WHO’s 2025 global immunization strategy emphasizes that achieving 95% coverage with two doses of measles-containing vaccine is the minimum threshold for interrupting transmission and preventing outbreaks. The Advisory Committee on Immunization Practices’ 2025 updated guidelines recommend that women of childbearing age verify their immunity status before pregnancy, as measles during pregnancy increases risks of miscarriage, preterm labor, and low birth weight.

MMR Vaccine Schedule by Age and Risk Group

Population Group	First Dose Timing	Second Dose Timing	Special Considerations
Children (standard)	12-15 months	4-6 years	Both doses required for school entry
Infants traveling internationally	6-11 months	12-15 months + 4-6 years	Early dose does not count toward two-dose series
Adults born after 1957	One dose minimum	Two doses for high-risk groups	Healthcare workers, college students, travelers need two doses
Healthcare workers	Two doses regardless of age	Documented immunity required	Serologic testing if vaccination records unavailable
Women of childbearing age	Verify immunity before pregnancy	MMR contraindicated during pregnancy	Wait 4 weeks after vaccination before conceiving

Sources: CDC 2025 Recommended Immunization Schedule; ACIP 2025 Updated Guidelines; WHO 2025 Global Immunization Strategy

How Are Current Measles Outbreaks Being Managed?

Public health authorities are responding to 2026 outbreaks through targeted vaccination campaigns, contact tracing, and quarantine measures, with ring vaccination — vaccinating all contacts of confirmed cases — proving the most effective containment strategy. The CDC’s 2026 outbreak response protocol recommends that unvaccinated individuals exposed to measles receive the MMR vaccine within 72 hours of exposure or immunoglobulin within 6 days for those at high risk, including infants under 12 months, pregnant women, and immunocompromised individuals. Schools and healthcare facilities in outbreak areas are excluding unvaccinated students and staff for 21 days after the last known exposure, following the CDC’s 2026 exclusion guidelines. According to the North Carolina Department of Health and Human Services’ 2026 outbreak report, the state has deployed mobile vaccination clinics to communities with vaccination rates below 80%, achieving a 15% increase in MMR coverage within affected zip codes. The WHO’s 2025 outbreak response guidelines emphasize that ring vaccination is the most effective strategy for containing outbreaks in communities with moderate coverage (80-94%), while mass vaccination campaigns are required in communities with coverage below 80%. The Texas Department of State Health Services’ 2026 outbreak report documented that the state’s largest outbreak, concentrated in an undervaccinated community in the Panhandle region, required over 10,000 contact tracing investigations and resulted in 47 hospitalizations among 186 confirmed cases.

What Is the Economic Impact of Measles Outbreaks?

Measles outbreaks impose substantial economic costs on public health systems, healthcare facilities, and affected families, with the CDC’s 2025 cost analysis estimating that a single outbreak response costs an average of $2.7 million per outbreak in direct public health expenditures. The CDC’s 2025 economic analysis found that each measles case costs approximately $47,000 in direct medical costs and public health response expenses, including contact tracing, laboratory testing, and vaccination campaigns. The University of Pittsburgh’s 2025 health economics study calculated that the 2019 US measles outbreaks — the largest since elimination — cost an estimated $3.8 million in public health response alone, with costs rising proportionally with outbreak size. For families, the American Academy of Pediatrics’ 2025 survey found that a child’s measles hospitalization results in an average of $12,000 in medical bills and 10 lost workdays for parents. The WHO’s 2025 global health economics report estimated that measles outbreaks cost low- and middle-income countries $1.2 billion annually in treatment costs and lost productivity.

How Do Vaccine Exemption Policies Contribute to Measles Resurgence?

Non-medical vaccine exemptions — including religious and philosophical exemptions — have expanded in 14 US states since 2020, creating communities where MMR coverage falls below the 85% threshold that allows sustained measles transmission. The CDC’s 2025 exemption analysis found that states allowing philosophical exemptions have average MMR coverage rates 3-5 percentage points lower than states with only medical exemptions. The Oregon Health Authority’s 2025 immunization survey documented that some Oregon counties have MMR exemption rates exceeding 15%, creating conditions where measles can spread rapidly once introduced. The American Academy of Pediatrics’ 2025 policy statement called for elimination of non-medical exemptions, citing the 2026 outbreaks as evidence that voluntary compliance alone cannot maintain herd immunity. The WHO’s 2025 global immunization strategy identified vaccine exemption clusters as the primary risk factor for measles reintroduction in countries that had previously achieved elimination status.

What Should You Do If You Think You Have Been Exposed to Measles?

If you believe you have been exposed to measles, immediately contact your healthcare provider or local health department by phone before visiting any medical facility to prevent further spread. The CDC’s 2026 exposure management guidelines recommend that unvaccinated individuals receive the MMR vaccine within 72 hours of exposure to potentially prevent infection, or immunoglobulin within 6 days for those at high risk. Monitor for symptoms — fever, cough, runny nose, and red eyes — for 21 days after exposure, as this is the maximum incubation period. If symptoms develop, isolate yourself from others immediately, especially from unvaccinated individuals, pregnant women, and immunocompromised people. The WHO’s 2025 clinical management guidelines emphasize that early supportive care — including vitamin A supplementation, hydration, and treatment of secondary infections — significantly reduces mortality in measles cases.